GI & Endoscopy

The American College of Gastroenterology's Public Relations Committee recognized 18 posters as newsworthy abstracts during ACG 2020, Oct. 23-28. 

COVID-19 patients with gastrointestinal symptoms had higher admission rates to hospitals and intensive care units and higher intubation rates than those without GI symptoms, according to a poster presented at ACG 2020, Oct. 23-28.

Using a noninvasive test to screen for colorectal cancer when a patient turned 45 years old added life years and decreased CRC incidence compared to starting screening when a patient turned 50 years old, according to a poster presented at…

Gastroenterology-focused Dr. Reddy's Laboratories was victim of a cyberattack, Pharmaceutical Technology reported Oct. 23.

  Here are the five most-read articles about gastroenterology and endoscopy from Oct. 15-23:

The Crohn's & Colitis Foundation is hosting its An Evening of Hope gala virtually Oct. 24 to support the Philadelphia/Delaware Valley Chapter.

CMS issued a proposal which declined to cover the first FDA-approved blood-based colorectal cancer screening test, but created a guideline for still-in-development tests to earn approval, according to an Oct. 16 memo.

In Wisconsin, Epic and Exact Sciences are decreasing COVID-19 test turnaround time by inputting results directly into Epic's MyChart program, Channel3000 reports.

Tucson-based University of Arizona researchers have identified a biomarker that appears in patients before they develop stomach cancer, the university announced Oct. 20.

  Here are five updates from gastroenterology companies and practices from the past week: